Fifth Third Bancorp
ESPR icon

Fifth Third Bancorp’s Esperion Therapeutics ESPR Stock Holding History

Fifth Third Bancorp’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43K Buy
+523
New +$1.66K ﹤0.01% 4089
2021
Q4 		– Sell
-50
Closed -$1K – 2695
2021
Q3 		$1K Hold
50
– – ﹤0.01% 2562
2021
Q2 		$1K Hold
50
– – ﹤0.01% 2380
2021
Q1 		$1K Hold
50
– – ﹤0.01% 2363
2020
Q4 		$1K Hold
50
– – ﹤0.01% 2283
2020
Q3 		$2K Hold
50
– – ﹤0.01% 2032
2020
Q2 		$3K Hold
50
– – ﹤0.01% 1930
2020
Q1 		$2K Buy
+50
New +$2.64K ﹤0.01% 1969
2015
Q4 		– Sell
-2,752
Closed -$65K – 2779
2015
Q3 		$65K Buy
+2,752
New +$173K ﹤0.01% 1311

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return